摘要
酒精性肝病（ALD）是由于长期大量饮酒所致的肝脏疾病。初期通常表现为脂肪肝，进而可发展成酒精性肝炎、肝纤维化和肝硬化；严重酗酒时可诱发广泛肝细胞坏死甚或急性肝衰竭。ALD是我国常见的慢性肝病之一，其发病率呈增长趋势且有年轻化和女性化倾向。为此，中华肝脏病学会2006年2月修定了《酒精性肝病诊疗指南》。
出处
《中华全科医师杂志》
2007年第4期201-203,共3页
Chinese Journal of General Practitioners
参考文献16
-
1范建高，贾继东．脂肪性肝病诊疗进展．北京：中华医学电子音像出版社，2006：63-69．
-
2Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis, 2004,24:217-232.
-
3Levitsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis, 2004,24:233-247.
-
4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量：271
-
5王颖,王炳元.酒精性肝病的诊断和治疗[J].中国实用内科杂志,2006,26(11):1667-1669. 被引量：7
-
6McCullough AJ, O' Connor JF. Alcoholic liver disease : proposed recommendations for the American College of Gastroenterology.Am J Gastroenterol, 1998,93:2022-2036.
-
7Jamal MM, Morgan TR. Liver disease in alcohol and hepatitis C.Best Pract Res Clin Gastroenterol, 2003,17:649-662.
-
8Phillips M, Curtis H, Portmann B, et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-a randomized clinical trial. J Hepatol, 2006,44:784-790.
-
9Mathurin P, Abdelnour M, Ramond M J, et al. Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone.Hepatology, 2003, 88:1363-1369.
-
10Louvet A, Diaz E, Texier F, et al. Prediction of mortality in severe alcoholic hepatitis : validation of Lille model and comparison to other prognostic scores. J Hepatol, 2006,44Suppl 24:S41.
二级参考文献15
-
1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量：108
-
2Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
-
3Sanyal AJ.American Gastroenterological Association technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.
-
4Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease.Invest Radiol,2000,35:319-324.
-
5Ataseven H,Yildrim MH,Yalniz M,et al.Correlation between computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis.J Hepatol,2003,38(Suppl 2):A4177.
-
6Farrell GC,George J,Pauline de la M.Hall,et al,eds.Fatty liver diseas:NASH and related disorders.Oxford:Blackwell Publishing,2005.159-207.
-
7McCullough AJ,O'Connor JF.Alcoholic liver disease:proposed recommendations for the American College of Gastroenterology.Am J Gastroenterol,1998,93:2022-2036.
-
8Stickel F,Hoehn B,Schuppan D,et al.Review article:Nutritional therapy in alcoholic liver disease.Aliment Pharmacol Ther,2003,18:357-373.
-
9Mathurin P,Mendenhall CL,Carithers RLJr,et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH):individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.J Hepatol,2002,36:480-487.
-
10Imperiale TF,O'Connor JB,McCullough AJ.Corticosteroids are effective in patients with severe alcoholic hepatitis.Am J Gastroenterol,1999,94:3066-3068.
共引文献276
-
1陈仕祥,范平,何维新,江军,熊志远.腺苷蛋氨酸治疗酒精性肝病疗效观察[J].中国医师进修杂志,2011,34(S01):66-67. 被引量：1
-
2郑有花(综述),王学红(审校).酒精性肝病的诊治进展[J].医学信息（医学与计算机应用）,2014,0(31):346-346.
-
3韩贤良,韩贤明.关于肝硬化死亡相关危险因素分析[J].医学信息（医学与计算机应用）,2014,0(31):126-126.
-
4关立新,李菊敏.酒精性肝病患者健康教育与治疗的依从性[J].中国实用医药,2007,2(21):88-89.
-
5詹雨林,李国航,骆欢.慢性肝病患者血清γ-谷氨酰转移酶测定的临床意义[J].中国实用医药,2007,2(25):42-43. 被引量：3
-
6沈洪,亓志刚,谢梅林.阿司匹林对高脂高糖诱发的大鼠脂肪性肝炎的治疗作用[J].中国药理学与毒理学杂志,2010,24(5):339-343. 被引量：1
-
7Li, Hong,Wang, You-Juan,Tan, Ke,Zeng, Li,Liu, Li,Liu, Feng-Jun,Zhou, Tao-You,Chen, En-Qiang,Tang, Hong.Prevalence and risk factors of fatty liver disease in Chengdu,Southwest China[J].Hepatobiliary & Pancreatic Diseases International,2009,8(4):377-382. 被引量：22
-
8中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志（电子版）,2010,2(4):49-53. 被引量：384
-
9肝纤维化中西医结合诊疗指南[J].中国肝脏病杂志（电子版）,2010,2(4):54-59. 被引量：108
-
10谢雯.脂肪性肝病的研究进展[J].中国临床医生杂志,2006,34(8):21-24. 被引量：7
同被引文献13
-
1中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志（电子版）,2010,2(4):49-53. 被引量：384
-
2刘建军,吴晓英.乙型肝炎病毒检测指标与临床关系研究近况[J].中华全科医师杂志,2005,4(4):226-228. 被引量：6
-
3Bonacini M, Louie S, Bzowej N, et al. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS, 2004,18 : 2039-2045.
-
4Yang RR, Gui XE, Gao SC, et al. Interaction of hepatitis B and C viruses in patients infected with HIV. J Acquit Immune Defic Syndr, 2008,48:505-506.
-
5Konopnieki D, Moeroft A, de Wit S, et ah Hepatitis B and H1V : prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS, 2005,19:593-601.
-
6Liaw YF, Tai DI, Chu CM, et al. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology, 1988,8:493-496.
-
7Sellier P, Schnepf N, Jarrin I, et al. Description of liver disease in a cohort of HIV/HBV coinfected patients. J Clin Virol ,2010, 47 : 13-17.
-
8Nunez M, Ramos B, Diaz-Pollan B, et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retroviruses, 2006,22:842-848.
-
9Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med, 2004,351 : 1521-1531.
-
10Diehl AM. Liver disease in alcohol abusers: clinical perspective. Alcohol, 2002, 27: 7-11.
引证文献2
-
1杨蓉蓉,桂希恩,高世成,熊勇,邓莉平,荣玉萍.人类免疫缺陷病毒并乙型肝炎病毒感染者终末期肝病影响因素分析[J].中华全科医师杂志,2011,10(9):641-644.
-
2魏玉统,潘留兰,孙寒,金珍婧,段立伟.酒精所致不典型脂肪肝二例分析[J].中华全科医师杂志,2014(4):325-326.
